Genenta Science S.p.A.

GNTA · NASDAQ
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$4-$8,908-$4-$5
Dep. & Amort.$0$45$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$847$0$0
Change in WC-$3$1,716$2$1
Other Non-Cash$1$6,297$0$0
Operating Cash Flow-$6-$6,238-$2-$4
Investing Activities
PP&E Inv.-$0-$4$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$16,380$0$0
Inv. Sales/Matur.$0$23,268$0$0
Other Inv. Act.-$4-$6,880$4-$5
Investing Cash Flow-$4$3$4-$5
Financing Activities
Debt Repay.$8$0$0$0
Stock Issued$0$0$0$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$3$271$0$0
Financing Cash Flow$10$271$0$0
Forex Effect$0-$23-$0-$0
Net Chg. in Cash$5$4,576$6-$12
Supplemental Information
Beg. Cash$0$6$0$12
End Cash$5$4,582$6$3,694
Free Cash Flow-$6-$6,243-$2-$4
Genenta Science S.p.A. (GNTA) Financial Statements & Key Stats | AlphaPilot